Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.

about

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.

Item

http://www.wikidata.org/entity/Q52751765

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inhibiting Nuclear Phospho-Pro ...... Onapristone in Uterine Cancer.

@en

Inhibiting Nuclear Phospho-Pro ...... Onapristone in Uterine Cancer.

@nl

type

Item

label

Inhibiting Nuclear Phospho-Pro ...... Onapristone in Uterine Cancer.

@en

Inhibiting Nuclear Phospho-Pro ...... Onapristone in Uterine Cancer.

@nl

prefLabel

Inhibiting Nuclear Phospho-Pro ...... Onapristone in Uterine Cancer.

@en

Inhibiting Nuclear Phospho-Pro ...... Onapristone in Uterine Cancer.

@nl

P1476

Inhibiting Nuclear Phospho-Pro ...... Onapristone in Uterine Cancer.

@en

P2093

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Archana S Nagaraja

http://www.w3.org/2001/XMLSchema#string

Dahai Jiang

http://www.w3.org/2001/XMLSchema#string

Fangrong Shen

http://www.w3.org/2001/XMLSchema#string

Heather J Dalton

http://www.w3.org/2001/XMLSchema#string

Jean M Hansen

http://www.w3.org/2001/XMLSchema#string

Jie Huang

http://www.w3.org/2001/XMLSchema#string

Kyunghee Noh

http://www.w3.org/2001/XMLSchema#string

Lingegowda S Mangala

http://www.w3.org/2001/XMLSchema#string

Michael McGuire

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

Classification and pharmacology of progestins

The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation

Progesterone receptor and the mechanism of action of progesterone antagonists

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.

Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.

Progesterone: the ultimate endometrial tumor suppressor.

Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer.

P304

464-473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-17-0006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cristina Ivan

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29237804

http://www.w3.org/2001/XMLSchema#string

P932

5805630

http://www.w3.org/2001/XMLSchema#string